Osteoporosis drugs in real-world clinical practice: an analysis of persistence

被引：29
作者：
Iolascon, Giovanni [1 ]
Gimigliano, Francesca [1 ]
Orlando, Valentina [2 ]
Capaldo, Annarita [1 ]
Di Somma, Carolina [3 ]
Menditto, Enrica [2 ]
机构：
[1] Univ Naples 2, Dept Med & Surg Specialties & Dent, Naples, Italy
[2] Univ Naples Federico II, Dept Pharm, Ctr Pharmacoecon & Drug Utilizat CIRFF, Naples, Italy
[3] IRCCS, SDN Fdn, Naples, Italy
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2013年 / 25卷
关键词：
Osteoporosis; Persistence; Database; Drug utilization; ADHERENCE; THERAPY; FRACTURE; DETERMINANTS; POPULATION; MANAGEMENT;
D O I：
10.1007/s40520-013-0127-5
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
The aim of our retrospective cohort study is to analyze the persistence rates in relation to antiosteoporotic drugs using administrative databases in the Campania Region. Patients, aged >= 40 years, were included if at least one prescription for any antiosteoporotic drugs had been filled in between January 1, 2009 and December 31, 2009. Overall, 37,594 patients were incident users of antiosteoporotic drugs. Among them, 15,978 patients had undergone spot-therapies. A total of 2,618 (14.1 %) were classified as switchers. Switching rates were highest for patients taking Alendronate 18.9 or Strontium Ranelate 15.0 and lower for patients taking Ibandronate 12.8 or Risedronate 10.8. In the overall population, 33.5 % of subjects were still on therapy after 6 months. At 1 year, persistence rates were: Ibandronate 21.6 %, Risedronate 15.8 %, Alendronate + Vitamin D 15.7 %, Raloxifene 14.3 %, Alendronate 12.6 % and Strontium Ranelate 5.0 %.
引用
收藏
页码：S137 / S141
页数：5
相关论文
共 15 条
  • [1] Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis
    Baio, Gianluca
    Barbagallo, Mario
    D'Avola, Giovanni
    Di Luccio, Andrea
    Di Tanna, Gian Luca
    Falaschi, Paolo
    Iolascon, Giovanni
    Malavolta, Nazzarena
    Robbiati, Federico
    Ulivieri, Fabio Massimo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (02) : 257 - 268
  • [2] Medication compliance and persistence: Terminology and definitions
    Cramer, Joyce A.
    Roy, Anuja
    Burrell, Anita
    Fairchild, Carol J.
    Fuldeore, Mahesh J.
    Ollendorf, Daniel A.
    Wong, Peter K.
    [J]. VALUE IN HEALTH, 2008, 11 (01) : 44 - 47
  • [3] The burden of hospitalization related to diabetes mellitus: A population-based study
    De Berardis, G.
    D'Ettorre, A.
    Graziano, G.
    Lucisano, G.
    Pellegrini, F.
    Cammarota, S.
    Citarella, A.
    Germinario, C. A.
    Lepore, V.
    Menditto, E.
    Nicolosi, A.
    Vitullo, F.
    Nicolucci, A.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (07) : 605 - 612
  • [4] Fracture outcomes related to persistence and compliance with oral bisphosphonates
    Gallagher, Arlene M.
    Rietbrock, Stephan
    Olson, Melvin
    van Staa, Tjeerd P.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (10) : 1569 - 1575
  • [5] Assessment of compliance with osteoporosis treatment and its consequences in a managed care population
    Huybrechts, KF
    Ishak, KJ
    Caro, JJ
    [J]. BONE, 2006, 38 (06) : 922 - 928
  • [6] Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
    Imaz, I.
    Zegarra, P.
    Gonzalez-Enriquez, J.
    Rubio, B.
    Alcazar, R.
    Amate, J. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 (11) : 1943 - 1951
  • [7] European guidance for the diagnosis and management of osteoporosis in postmenopausal women
    Kanis, J. A.
    Burlet, N.
    Cooper, C.
    Delmas, P. D.
    Reginster, J. -Y.
    Borgstrom, F.
    Rizzoli, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 399 - 428
  • [8] Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis
    Kothawala, Prajesh
    Badamgarav, Enkhe
    Ryu, Seonyoung
    Miller, Ross M.
    Halbert, R. J.
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (12) : 1493 - 1501
  • [9] Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey
    Piscitelli, P.
    Iolascon, G.
    Gimigliano, F.
    Muratore, M.
    Camboa, P.
    Borgia, O.
    Forcina, B.
    Fitto, F.
    Robaud, V.
    Termini, G.
    Rini, G. B.
    Gianicolo, E.
    Faino, A.
    Rossini, M.
    Adami, S.
    Angeli, A.
    Distante, A.
    Gatto, S.
    Gimigliano, R.
    Guida, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (02) : 211 - 219
  • [10] Low Incidence of Anti-Osteoporosis Treatment After Hip Fracture
    Rabenda, Veronique
    Vanoverloop, Johan
    Fabri, Valerie
    Mertens, Raf
    Sumkay, Francois
    Vannccke, Carine
    Deswaef, Andre
    Verpooten, Gert A.
    Reginster, Jean-Yves
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A (10) : 2142 - 2148
12